Pearl teams up with Hoosiers Work for Health

Pearl announces its partnership with the Hoosiers Work for Health coalition. Hoosiers Work for Health is the Indiana chapter of a national initiative that unites health consumers, biopharmaceutical company employees, vendors, suppliers and other business and community...

Tufts CSDD releases new report

In 2012, an all-time high of 28,000 principal investigators participated in FDA regulated research, according to a study in the March/April Tufts Center for the Study of Drug Development (CSDD) Impact Report. However, compound annual growth in the number of active...

First INpact meeting of 2013

Pearl staff is attending the first INpact lunch meeting of 2013 on Wednesday, January 23rd.   INpact is focused on supporting the medical device industry in Indiana. Please attend the lunch to network and learn more about the new bimonthly meeting format. Time: ...

Sunshine Act Limiting US Drug Research?

In a recent article, The Association of Clinical Research Organizations (ACRO) has voiced its concern that the Sunshine Act may have negative effects on US drug research. The Sunshine Act requires the reporting of payments made by biopharma to physicians and was...